Prognostic Nomogram for the Overall Survival of Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International - United States
doi 10.1155/2019/5652935
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Comparison of the Freiburg and Charlson Comorbidity Indices in Predicting Overall Survival in Elderly Patients With Newly Diagnosed Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Improvement in Renal Function and Its Impact on Survival in Patients With Newly Diagnosed Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Prognostic Nomogram Incorporating Inflammatory Cytokines for Overall Survival in Patients With Aggressive Non-Hodgkin's Lymphoma

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Treatments for Newly Diagnosed Multiple Myeloma: Analysis of Survival Data and Cost-Effectiveness Evaluation.

Oncology Reports
MedicineCancer ResearchOncology
1998English

A Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Time to Plateau as a Predictor of Survival in Newly Diagnosed Multiple Myeloma

American Journal of Hematology
Hematology
2018English

Daratumumab in Untreated Newly Diagnosed Multiple Myeloma

Therapeutic Advances in Hematology
Hematology
2019English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy